Form 4: Lexaria Bioscience Corp. Director Albert L. Reese Jr. Reports Acquisition of Stock Options
SEC Form 4
Director Albert L. Reese Jr. reports acquiring 5,000 stock options in Lexaria Bioscience Corp.
Summary
- On May 10, 2024, Albert L. Reese Jr., a director of Lexaria Bioscience Corp., filed a Form 4.
- The report details a transaction on April 26, 2024, where Reese acquired 5,000 stock options with an exercise price of $2.36.
- These options are exercisable from April 26, 2024, and expire on April 26, 2029.
- Reese also reported owning 10,917 common shares directly.
- Following the reported transaction, Reese beneficially owns a total of 20,000 stock options.
Sentiment
Score: 6
Explanation: The sentiment is neutral. It's a standard disclosure of stock option acquisition by a director, which doesn't inherently indicate positive or negative news.
Positives
- A director's acquisition of stock options can be seen as a positive signal, indicating confidence in the company's future performance.
Industry Context
This filing is a routine disclosure related to insider transactions, which are common in publicly traded companies. It provides transparency into the actions of company insiders.
Stakeholder Impact
- Shareholders may view the director's acquisition of stock options as a sign of confidence in the company's future prospects.
Key Dates
| Date | Description |
|---|---|
| 02/01/2021 | Date exercisable for 3,400 stock options at $3.00, expiring 02/01/2026 |
| 03/08/2022 | Date exercisable for 3,400 stock options at $3.39, expiring 03/08/2027 |
| 10/12/2022 | Date exercisable for 3,200 stock options at $1.96, expiring 10/12/2027 |
| 05/09/2023 | Shareholder approval received for repricing of stock options from $4.80. |
| 07/25/2023 | Date exercisable for 5,000 stock options at $0.87, expiring 07/25/2028 |
| 04/26/2024 | Transaction date: Acquisition of 5,000 stock options at $2.36, expiring 04/26/2029 |
| 05/10/2024 | Date of Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.